Highlights
- You are not imagining it. The bloating, food sensitivities, and digestive changes that arrive in your forties are not random. They have a hormonal cause, and that cause has a clinical response.
- Your gut and your hormones are talking to each other. Estrogen receptors line the entire gastrointestinal tract. When Estrogen falls, the gut feels it, sometimes before you do.
- What happens in your gut shows up on your face. Gut inflammation does not stay in the gut. It travels, and one of the places it surfaces is your skin: dullness, uneven tone, sensitivity that was not there before.
- There is a peptide with thirty years of research behind it. BPC-157 is derived from a protein naturally present in your own gastric juice. It is one of the most studied gut-repair compounds available, and it is available at Menovivre under proper clinical supervision.
The bloating that started in your forties and never really left. The foods that suddenly disagree with you. The digestion that feels unpredictable in a way it never used to.
If your gut has not felt like itself since perimenopause, you are far from alone. And it is not in your head.
The gut is one of the first places to register the hormonal shifts of menopause. Not because something has gone wrong with you, but because estrogen plays a much bigger role in gut function than most women are ever told. When it falls, the gut responds.
At Menovivre, we see this connection every day. This article explains what is actually happening, why it matters beyond the discomfort, and how targeted peptide therapy offers something that diet changes and probiotics alone often cannot.
Quick Answer
What Estrogen Does to Your Gut
Here is something most women are never told: estrogen receptors line the entire gastrointestinal tract, from the stomach to the colon.
That matters because it means the gut is directly tuned to estrogen levels. When estrogen is stable, the gut lining is resilient, the microbiome is diverse, and digestion tends to be predictable. When estrogen falls, as it does during perimenopause, the gut registers that change immediately.
Research shows that estrogen plays a direct role in maintaining the integrity of the gut epithelial barrier, the single-cell-thick lining that separates the gut contents from the bloodstream. When estrogen declines, gut permeability increases: the tight junctions between epithelial cells loosen, allowing bacterial fragments, undigested food particles, and inflammatory compounds to pass into the bloodstream. This is what is commonly described as leaky gut, and it is not a fringe concept. It is a measurable physiological change with documented links to systemic inflammation, skin changes, joint pain, and metabolic disruption.
Estrogen also plays a key role in shaping the gut microbiome itself. After menopause, microbial diversity decreases, populations of beneficial bacteria decline, and the microbial balance shifts in ways that affect everything from mood to metabolism.
A 2025 review published in Frontiers in Endocrinology found that the gut microbiota is a key regulator of estrogen status in menopausal women, with the community of gut bacteria that recycle estrogen playing a central role in circulating hormone levels. When that community is disrupted, the hormonal deficit of menopause deepens. It becomes a cycle: less estrogen disrupts the gut, a disrupted gut produces less estrogen. Breaking that cycle means addressing the gut directly.
The Gut-Skin Axis: Why Gut Health Shows Up on Your Face
Gut health and skin health might seem like separate conversations. They are not.
When the gut lining becomes permeable, the inflammation it generates does not stay local. It enters the bloodstream and travels. One of the most visible places it surfaces is the skin: the dullness that appeared alongside the bloating, the redness that came from nowhere, the tone that feels less even than it used to. These are not unconnected. They are the same underlying process showing up in different places.
A review in the American Journal of Lifestyle Medicine confirmed a causal relationship between gut dysbiosis and immune-mediated skin conditions, with disrupted gut barrier function identified as a primary driver. In practical terms, this means that approaches to skin health in midlife that ignore the gut are working on one side of the same equation.
What Happens in the Gut and Where It Shows Up
BPC-157: The Gut Repair Peptide
BPC-157 is a peptide your body already knows.
It is derived from a protective protein naturally present in human gastric juice, where it plays a role in maintaining the integrity of the gut lining. The synthetic version reproduces that same signal, and it has been studied in the context of gastrointestinal health for over thirty years.
Thirty years is worth pausing on. This is not something that appeared on TikTok this year. It is one of the most consistently studied peptides in the gut medicine literature, with a body of preclinical evidence that very few therapeutic compounds in this space can match.
What BPC-157 does in the gut
In preclinical models, BPC-157 has consistently demonstrated the ability to restore tight junction proteins, including claudin, occludin, and ZO-1, which are the molecular locks that keep the gut lining sealed. A systematic review in the American Journal of Gastroenterology covering 36 studies from 1993 to 2025 found that BPC-157 enhances growth hormone receptor expression, modulates pathways involved in cell growth and angiogenesis, and reduces inflammatory cytokines, with demonstrated effects across models of IBD, GI ulcers, NSAID-induced gut injury, and anastomotic healing.
It also promotes the organised proliferation of intestinal epithelial cells, rebuilding a compromised gut wall through tissue granulation and mucosal regeneration. And it has demonstrated systemic anti-inflammatory effects that extend well beyond the gut itself.
Why it is particularly relevant in midlife
For women in perimenopause and menopause, BPC-157 addresses something that HRT alone does not fully reach. Restoring estrogen moderates many of the downstream effects of the menopausal transition. But the gut lining does not simply return to normal when estrogen is replaced. The damage to gut barrier integrity, the shift in the microbiome, and the ongoing inflammatory load often need to be addressed directly.
BPC-157 is one of the few therapeutic compounds with meaningful preclinical evidence specifically for restoring gut barrier integrity. When used as part of a clinically supervised protocol alongside hormonal support and nutritional assessment, it addresses the gut dimension of the menopausal transition in a way that lifestyle changes and supplements alone typically cannot.
Oral vs injectable administration
One notable property of BPC-157 is that, unlike most peptides, it is stable in gastric acid. This means it can be taken orally for gut-specific applications and still reach the intestinal epithelium intact. For women seeking gut-targeted support, oral BPC-157 is a viable route. Injectable forms are also available for more systemic effects. Your clinician will advise the appropriate route based on your clinical picture.
What a Clinically Supervised Gut Protocol Looks Like
A single peptide does not fix a gut that has been struggling through a hormonal transition. What actually helps is understanding what is driving the problem, and building a plan around that. Here is how we approach it.
- Gut health history. A detailed review of your digestive symptoms, their timeline, and how they relate to your hormonal history.
- Blood panel and inflammatory markers. Assessing intestinal permeability markers, inflammatory cytokines, and the metabolic picture that gut inflammation influences.
- Nutritional assessment. Understanding what you are eating, how it is affecting your gut, and what changes, including fibre diversity, fermented foods, and specific supplements, might support microbiome recovery alongside peptide therapy.
- Hormonal context. Because gut health and hormonal health are directly connected, any gut protocol at Menovivre is considered alongside your broader hormonal picture, including whether HRT is appropriate.
Your Gut Has Been Trying to Tell You Something
The bloating, the sensitivities, the unpredictability. You have probably been managing these quietly, adjusting what you eat, wondering if you are just stressed, telling yourself it is not serious enough to mention.
It is serious enough. And it is not something you have to keep navigating alone.
These symptoms have a cause, and that cause has a clinical response. You do not have to accept them as the new normal.
If your gut has not felt right since perimenopause, we would like to help. You can request an appointment without a GP referral. Bring your symptoms, bring your history, and we will take it from there, together.
Frequently Asked Questions
Q1: Is bloating in menopause normal?
Q2. What is leaky gut, and is it a real condition?
Q3. How does estrogen affect the gut?
Q4. Is BPC-157 safe?
Q5. Can I take gut peptide therapy alongside HRT?
Q6. How quickly does gut peptide therapy work?
Q7. I have tried probiotics and dietary changes without much improvement. Can peptide therapy help?
Q8. Do I need a referral to be seen at Menovivre?
